A Phase II Study of Post-Remission Therapy with Azacitidine (AZA) in Patients with AML Post-MDS and High-Risk MDS: A GFM Group Study

被引：6

作者：

Gardin, Claude ^{[1
]}

Prebet, Thomas ^{[2
]}

Bouabdallah, Krimo ^{[3
]}

Caillot, Denis ^{[4
]}

Guerci, Agnes ^{[5
]}

Raffoux, Emmanuel ^{[6
]}

Marolleau, Jean Pierre ^{[7
]}

Pautas, Cecile ^{[8
]}

Banos, Anne ^{[9
]}

Himberlin, Chantal ^{[10
]}

Taksin, Anne-Laure ^{[11
]}

Pigneux, Arnaud ^{[3
]}

Thomas, Xavier ^{[12
]}

Jernival, Tony ^{[1
]}

Vey, Norbert ^{[2
]}

Dreyfus, Francois ^{[13
]}

Chevret, Sylvie ^{[14
]}

Dombret, Herve ^{[14
]}

Fenaux, Pierre ^{[15
,16
]}

机构：

[1] Grp Francophone Myelodysplasies, Bobigny, France

[2] Inst J Paoli I Calmettes, Dept Hematol, F-13009 Marseille, France

[3] CHU Bordeaux, Bordeaux, France

[4] CHU Bocage, IFM, Dijon, France

[5] Med Serv, Nancy, France

[6] Univ Paris 07, Hop St Louis, AP HP, EA 3518,Dept Hematol, Paris, France

[7] CHU Amiens Sud, Bobigny, France

[8] Hop Henri Mondor, AP HP, F-94010 Creteil, France

[9] CH Bayonne France, Bayonne, France

[10] Hop Robert Debre, Unite Hematol Clin, Reims, France

[11] CHU Mignot Versailles, Versailles, France

[12] CHU Herriot Lyon, Bobigny, France

[13] Hop Cochin, AP HP, F-75674 Paris, France

[14] Hop St Louis, AP HP, DBIM, F-75010 Paris, France

[15] Univ Paris 13, Hop Avicenne, AP HP, Bobigny, France

[16] Inst Gustave Roussy, INSERM 848, Bobigny, France

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

10.1182/blood.V114.22.844.844

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：348 / 348

页数：1